GEFITINIB SANDOZ 250 MG COMPRIMIDOS RECUBIERTOS CON PELCULA EFG
GEFITINIB SANDOZ 250 MG COMPRIMIDOS RECUBIERTOS CON PELCULA EFG
Commercialized
Register Number
83716
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Dec 28, 2018
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number83716
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
GEFITINIBActive
Quantity: 250 mg
Name: GEFITINIB
ATC CLASSIFICATION (3)
L01E
L01EB
L01EB01